Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stroke

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 125 articles:
HTML format



Single Articles


    November 2022
  1. HIJAZI Z, Benz AP, Lindback J, Alexander JH, et al
    Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
    Eur Heart J. 2022 Nov 16. pii: 6830621. doi: 10.1093.
    PubMed     Abstract available


  2. BONACA MP, Im K, Magnani G, Bansilal S, et al
    Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2022 Nov 11. pii: 6823782. doi: 10.1093.
    PubMed     Abstract available


  3. LYTH J, Svennberg E, Bernfort L, Aronsson M, et al
    Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.
    Eur Heart J. 2022 Nov 9. pii: 6806218. doi: 10.1093.
    PubMed     Abstract available


  4. LAUDER L, Mahfoud F, Azizi M, Bhatt DL, et al
    Hypertension management in patients with cardiovascular comorbidities.
    Eur Heart J. 2022 Nov 7. pii: 6808663. doi: 10.1093.
    PubMed     Abstract available


  5. FONSECA HAR, Furtado RHM, Zimerman A, Lemos PA, et al
    Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
    Eur Heart J. 2022;43:4378-4388.
    PubMed     Abstract available


    October 2022
  6. MEYRE PB, Blum S, Hennings E, Aeschbacher S, et al
    Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
    Eur Heart J. 2022 Oct 26. pii: 6773770. doi: 10.1093.
    PubMed     Abstract available


  7. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    PubMed    


  8. TARDIF JC, Pfeffer MA, Kouz S, Koenig W, et al
    Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
    Eur Heart J. 2022;43:3947-3956.
    PubMed     Abstract available


  9. ZHOU WX, Tang H, Wei X
    Identifies culprit of cerebral infarction: contrast echocardiography of right heart through uncommon route.
    Eur Heart J. 2022;43:3813.
    PubMed    


    September 2022
  10. VAN DEN ENDEN AJM, Meuwese CL, Van Mieghem NM
    Changing biventricular mechanics during thrombectomy for intermediate high-risk pulmonary embolism.
    Eur Heart J. 2022 Sep 21. pii: 6710213. doi: 10.1093.
    PubMed    


  11. MESSERLI FH, O'Donnell M, Mente A, Yusuf S, et al
    Settling the controversy of salt substitutes and stroke: sodium reduction or potassium increase?
    Eur Heart J. 2022;43:3365-3367.
    PubMed    


  12. HESS CN, Bonaca MP
    Risk of remnants and remnant risk in peripheral artery disease.
    Eur Heart J. 2022;43:3270-3272.
    PubMed    


  13. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2022;43:3148-3161.
    PubMed     Abstract available


    August 2022
  14. KRONENBERG F, Mora S, Stroes ESG, Ference BA, et al
    Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
    Eur Heart J. 2022 Aug 29. pii: 6670882. doi: 10.1093.
    PubMed     Abstract available


  15. ECKARDT L, Sehner S, Suling A, Borof K, et al
    Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST - AFNET 4 trial.
    Eur Heart J. 2022 Aug 29. pii: 6675568. doi: 10.1093.
    PubMed     Abstract available


  16. KONDO T, Abdul-Rahim AH, Talebi A, Abraham WT, et al
    Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
    Eur Heart J. 2022 Aug 26. pii: 6676501. doi: 10.1093.
    PubMed     Abstract available


  17. SAGRIS D, Shantsila E, Lip GYH
    Stroke risk stratification in patients with heart failure and sinus rhythm.
    Eur Heart J. 2022 Aug 26. pii: 6676507. doi: 10.1093.
    PubMed    


  18. VOLPE M, Patrono C
    One-shot thrombolysis for the management of acute ischaemic stroke.
    Eur Heart J. 2022 Aug 18. pii: 6670981. doi: 10.1093.
    PubMed    


    July 2022
  19. LIP GYH, Lane DA, Lenarczyk R, Boriani G, et al
    Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2022;43:2442-2460.
    PubMed     Abstract available


  20. BLANC-VANNET S, Vautrin E, Piliero N
    Massive device thrombosis, multiple embolisms, and delayed-onset heparin-induced thrombocytopenia: a rare but severe complication of patent foramen ovale closure.
    Eur Heart J. 2022;43:2425.
    PubMed    


    May 2022
  21. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    PubMed     Abstract available


  22. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    PubMed     Abstract available


  23. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    PubMed     Abstract available


  24. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    PubMed    


  25. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
    Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Eur Heart J. 2022;43:1715-1727.
    PubMed     Abstract available


    April 2022
  26. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed     Abstract available


    March 2022
  27. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
    Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
    Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
    PubMed     Abstract available


  28. MCINTYRE WF, Linz D
    Atrial fibrillation and stroke: who is low risk and what are we going to do about it?
    Eur Heart J. 2022 Mar 10. pii: 6546014. doi: 10.1093.
    PubMed    


    February 2022
  29. ROSSI A, Mikail N, Bengs S, Haider A, et al
    Heart-brain interactions in cardiac and brain diseases: why sex matters.
    Eur Heart J. 2022 Feb 23. pii: 6534632. doi: 10.1093.
    PubMed     Abstract available


  30. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
    Frailty and cardiovascular mortality in more than 3 million US Veterans.
    Eur Heart J. 2022;43:818-826.
    PubMed     Abstract available


  31. JARED BUNCH T, Steinberg BA
    Clinical strokes in atrial fibrillation: the tip of the iceberg.
    Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
    PubMed    


  32. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
    Silent brain infarcts impact on cognitive function in atrial fibrillation.
    Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
    PubMed     Abstract available


  33. COSEMANS JMEM
    Platelet-derived MMP-2 in the prevention of plaque formation: how many strokes is par?
    Eur Heart J. 2022;43:515-517.
    PubMed    


  34. NURMOHAMED NS, Belo Pereira JP, Hoogeveen RM, Kroon J, et al
    Targeted proteomics improves cardiovascular risk prediction in secondary prevention.
    Eur Heart J. 2022 Feb 9. pii: 6525629. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  35. NARDUCCI ML, Volpe M
    Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
    Eur Heart J. 2022;43:261-262.
    PubMed    


  36. NOUBIAP JJ
    The association of atrial fibrillation with mortality in patients with breast cancer.
    Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
    PubMed    


  37. WEGENER S
    Triggers of stroke: anger, emotional upset, and heavy physical exertion. New insights from the INTERSTROKE study.
    Eur Heart J. 2022;43:210-212.
    PubMed    


  38. NICHOLLS M
    Preventing stroke in atrial fibrillation patients.
    Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
    PubMed    


  39. LEHTISALO J, Rusanen M, Solomon A, Antikainen R, et al
    Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial.
    Eur Heart J. 2022 Jan 20. pii: 6512207. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  40. LABORI F, Persson J, Bonander C, Jood K, et al
    Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
    PubMed     Abstract available


  41. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    PubMed     Abstract available


  42. KLOK FA, Ageno W, Ay C, Back M, et al
    Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on A
    Eur Heart J. 2021 Dec 7. pii: 6454843. doi: 10.1093.
    PubMed     Abstract available


  43. SMYTH A, O'Donnell M, Hankey GJ, Rangarajan S, et al
    Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE study.
    Eur Heart J. 2021 Dec 1. pii: 6447061. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  44. GASBARRINO K, Di Iorio D, Daskalopoulou SS
    Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease.
    Eur Heart J. 2021 Nov 26. pii: 6444192. doi: 10.1093.
    PubMed     Abstract available


  45. CAMEN S, Schnabel RB
    Genetics, atrial cardiomyopathy, and stroke: enough components for a sufficient cause?
    Eur Heart J. 2021;42:4533-4535.
    PubMed    


  46. MARAZITI G, Vinson DR, Becattini C
    Echocardiography for risk stratification in patients with pulmonary embolism at low risk of death: a response.
    Eur Heart J. 2021 Nov 11. pii: 6425623. doi: 10.1093.
    PubMed    


    October 2021
  47. FEDOROWSKI A, Siller-Matula JM, Patti G
    Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango.
    Eur Heart J. 2021 Oct 23. pii: 6408927. doi: 10.1093.
    PubMed    


  48. ESCANED J, Cao D, Baber U, Nicolas J, et al
    Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
    Eur Heart J. 2021 Oct 18. pii: 6400337. doi: 10.1093.
    PubMed     Abstract available


  49. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
    Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
    Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
    PubMed     Abstract available


  50. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
    Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
    Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  51. RUSSO AM
    Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
    Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
    PubMed    


  52. SPOSATO LA, Aspberg S, Scheitz JF, Fisher M, et al
    The World Stroke Organization Brain & Heart Task Force: collaborations between stroke physicians and cardiologists.
    Eur Heart J. 2021;42:3594-3596.
    PubMed    


  53. OYAMA K, Giugliano RP, Tang M, Bonaca MP, et al
    Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial.
    Eur Heart J. 2021 Sep 19. pii: 6372436. doi: 10.1093.
    PubMed     Abstract available


  54. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    PubMed     Abstract available


  55. DEFILIPPIS AP, Trainor PJ, Thanassoulis G, Brumback LC, et al
    Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis.
    Eur Heart J. 2021 Sep 11. pii: 6368900. doi: 10.1093.
    PubMed     Abstract available


  56. KANG EH, Park EH, Shin A, Song JS, et al
    Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.
    Eur Heart J. 2021 Sep 11. pii: 6368678. doi: 10.1093.
    PubMed     Abstract available


  57. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    PubMed     Abstract available


  58. GINSBERG HN, Packard CJ, Chapman MJ, Boren J, et al
    Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.
    Eur Heart J. 2021 Sep 2. pii: 6362485. doi: 10.1093.
    PubMed     Abstract available


  59. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
    Day-to-day measurement of physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  60. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
    Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
    PubMed     Abstract available


  61. KRANTZ MJ, Debus SE, Hsia J, Patel MR, et al
    Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
    Eur Heart J. 2021 Aug 25. pii: 6357238. doi: 10.1093.
    PubMed     Abstract available


  62. STEFANINI GG, Briguori C, Cao D, Baber U, et al
    Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
    Eur Heart J. 2021 Aug 23. pii: 6356261. doi: 10.1093.
    PubMed     Abstract available


  63. YOUNG KA, Bonnichsen CR
    Left ventricular pseudoaneurysm as source of recurrent stroke.
    Eur Heart J. 2021;42:3106.
    PubMed    


  64. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
    Eur Heart J. 2021 Aug 14. pii: 6352178. doi: 10.1093.
    PubMed     Abstract available


  65. BECATTINI C, Cimini LA, Agnelli G
    Home management or hospital admission for low-risk pulmonary embolism? Clinical scores versus pragmatic assessment.
    Eur Heart J. 2021 Aug 13. pii: 6350777. doi: 10.1093.
    PubMed    


  66. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    PubMed     Abstract available


  67. HAN Y, Hu Y, Yu C, Guo Y, et al
    Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study.
    Eur Heart J. 2021 Aug 1. pii: 6333295. doi: 10.1093.
    PubMed     Abstract available


  68. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
    Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
    PubMed     Abstract available


  69. KIM MS, Kim WJ, Khera AV, Kim JY, et al
    Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies.
    Eur Heart J. 2021 Aug 1. pii: 6333298. doi: 10.1093.
    PubMed     Abstract available


  70. REIFFEL JA
    When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
    Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
    PubMed    


    July 2021
  71. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed     Abstract available


  72. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    PubMed     Abstract available



  73. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    Eur Heart J. 2021;42:2455-2467.
    PubMed     Abstract available


    June 2021
  74. BECATTINI C, Maraziti G, Vinson DR, Ng ACC, et al
    Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis.
    Eur Heart J. 2021 Jun 28. pii: 6310284. doi: 10.1093.
    PubMed     Abstract available


  75. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
    Salt reduction to prevent hypertension: the reasons of the controversy.
    Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
    PubMed     Abstract available


  76. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    PubMed     Abstract available


  77. CREA F
    Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
    Eur Heart J. 2021;42:2137-2140.
    PubMed    


  78. TSIMIKAS S
    Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly.
    Eur Heart J. 2021;42:2197-2200.
    PubMed    


    May 2021
  79. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    PubMed     Abstract available


  80. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    PubMed     Abstract available


  81. CREA F
    New challenges in vascular biology and medicine: from unravelling the mechanisms of neointima formation to the prevention of amputations and of ischaemic stroke.
    Eur Heart J. 2021;42:1715-1719.
    PubMed    


  82. IMAZIO M, Nidorf M
    Colchicine and the heart.
    Eur Heart J. 2021 May 7. pii: 6271392. doi: 10.1093.
    PubMed     Abstract available


  83. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    PubMed    


    April 2021
  84. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    PubMed    


    March 2021
  85. DE JONG Y, Fu EL, van Diepen M, Trevisan M, et al
    Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function.
    Eur Heart J. 2021 Mar 26. pii: 6188994. doi: 10.1093.
    PubMed     Abstract available


  86. FIOLET ATL, Opstal TSJ, Mosterd A, Eikelboom JW, et al
    Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2021 Mar 26. pii: 6188997. doi: 10.1093.
    PubMed     Abstract available


  87. AJJAN RA, Kietsiriroje N, Badimon L, Vilahur G, et al
    Antithrombotic therapy in diabetes: which, when, and for how long?
    Eur Heart J. 2021 Mar 25. pii: 6186730. doi: 10.1093.
    PubMed     Abstract available


  88. OYAMA K, Giugliano RP, Berg DD, Ruff CT, et al
    Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2021 Mar 24. pii: 6184829. doi: 10.1093.
    PubMed     Abstract available


  89. ARNOLD M, Schweizer J, Nakas CT, Schutz V, et al
    Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.
    Eur Heart J. 2021 Mar 8. pii: 6168588. doi: 10.1093.
    PubMed     Abstract available


  90. REED GW, Krishnaswamy A, Kapadia SR
    Silent brain infarction after TAVR: common but of unclear significance.
    Eur Heart J. 2021;42:1016-1018.
    PubMed    


    February 2021
  91. BUTT JH, Fosbol EL, Gerds TA, Andersson C, et al
    All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study.
    Eur Heart J. 2021 Feb 24. pii: 6149000. doi: 10.1093.
    PubMed     Abstract available


  92. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
    Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  93. SEMERANO A, Saliou G, Sanvito F, Genchi A, et al
    Fishing an anemone in the brain: embolized cardiac fibroelastoma revealed after stroke thrombectomy.
    Eur Heart J. 2021 Jan 31. pii: 6124843. doi: 10.1093.
    PubMed    


  94. PRISTIPINO C, Germonpre P, Toni D, Sievert H, et al
    European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions.
    Eur Heart J. 2021 Jan 28. pii: 6122426. doi: 10.1093/eurheartj/ehaa1070.
    PubMed     Abstract available


  95. RIENSTRA M, Van Gelder IC
    Incidence and outcome of atrial fibrillation: diversity throughout Europe.
    Eur Heart J. 2021 Jan 25. pii: 6120041. doi: 10.1093/eurheartj/ehaa1078.
    PubMed    



  96. Corrigendum to: Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascula
    Eur Heart J. 2021;42:307.
    PubMed    


  97. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
    Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions
    Eur Heart J. 2021;42:298-307.
    PubMed     Abstract available


  98. CREA F
    Management of ischaemic stroke, prognostic impact of procedural myocardial injury, and antiplatelet treatment: the many facets of interventional cardiology.
    Eur Heart J. 2021;42:289-291.
    PubMed    


    December 2020
  99. SCHUBERT J, Lindahl B, Melhus H, Renlund H, et al
    Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Eur Heart J. 2020 Dec 24. pii: 6047259. doi: 10.1093/eurheartj/ehaa1011.
    PubMed     Abstract available


  100. PETERMANN-ROCHA F, Parra-Soto S, Gray S, Anderson J, et al
    Vegetarians, fish, poultry, and meat-eaters: who has higher risk of cardiovascular disease incidence and mortality? A prospective study from UK Biobank.
    Eur Heart J. 2020 Dec 14. pii: 6032616. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  101. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
    Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment.
    Eur Heart J. 2020 Nov 7. pii: 5960214. doi: 10.1093.
    PubMed     Abstract available


  102. NANJO A, Evans H, Direk K, Hayward AC, et al
    Prevalence, incidence, and outcomes across cardiovascular diseases in homeless individuals using national linked electronic health records.
    Eur Heart J. 2020;41:4011-4020.
    PubMed     Abstract available


    October 2020
  103. LIUZZO G, Patrono C
    Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.
    Eur Heart J. 2020 Oct 17. pii: 5927543. doi: 10.1093.
    PubMed    


    September 2020
  104. WALLENTIN L, Lindback J, Eriksson N, Hijazi Z, et al
    Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
    Eur Heart J. 2020 Sep 27. pii: 5912214. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  105. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    PubMed     Abstract available


  106. BOUABDALLAOUI N, Tardif JC, Waters DD, Pinto FJ, et al
    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Eur Heart J. 2020 Aug 29. pii: 5898840. doi: 10.1093.
    PubMed     Abstract available


  107. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Aug 29. pii: 5899003. doi: 10.1093.
    PubMed    


  108. FERLINI M, Mauri S
    Variable rate of stroke after transcatheter aortic valve replacement with self-expandable valves: more doubts than certainties.
    Eur Heart J. 2020 Aug 18. pii: 5893661. doi: 10.1093.
    PubMed    


  109. THIELE H, Abdel-Wahab M, Desch S
    Stroke rates after transcatheter aortic valve replacement: does valve choice play a role?
    Eur Heart J. 2020 Aug 18. pii: 5893660. doi: 10.1093.
    PubMed    


    July 2020
  110. MENTE A, Dehghan M, Yusuf S
    Diet and health: the need for new and reliable approaches.
    Eur Heart J. 2020;41:2641-2644.
    PubMed    


    April 2020
  111. LINDE C
    Integrated care for atrial fibrillation: time for widespread use.
    Eur Heart J. 2020 Apr 13. pii: 5819644. doi: 10.1093.
    PubMed    


    February 2020
  112. HUANG HK, Liu PP, Hsu JY, Lin SM, et al
    Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study.
    Eur Heart J. 2020 Feb 1. pii: 5718429. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  113. GUNDLUND A, Olesen JB, Butt JH, Christensen MA, et al
    One-year outcomes in atrial fibrillation presenting during infections: a nationwide registry-based study.
    Eur Heart J. 2019 Dec 17. pii: 5680017. doi: 10.1093.
    PubMed     Abstract available


  114. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
    Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
    Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  115. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    PubMed    


    October 2019
  116. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  117. WIJTVLIET EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, et al
    Nurse-led vs. usual-care for atrial fibrillation.
    Eur Heart J. 2019 Sep 23. pii: 5572602. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  118. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
    Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Eur Heart J. 2019;40:2595-2604.
    PubMed     Abstract available


    June 2019
  119. KOTECHA D, Castella M
    Is it time to treat post-operative atrial fibrillation just like regular atrial fibrillation?
    Eur Heart J. 2019 Jun 25. pii: 5523037. doi: 10.1093.
    PubMed    


  120. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    PubMed     Abstract available


  121. PIAZZA G, Hurwitz S, Galvin CE, Harrigan L, et al
    Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
    Eur Heart J. 2019 Jun 22. pii: 5521151. doi: 10.1093.
    PubMed     Abstract available


  122. KIM D, Yang PS, Yu HT, Kim TH, et al
    Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort.
    Eur Heart J. 2019 Jun 18. pii: 5520105. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  123. FRIBERG L, Andersson T, Rosenqvist M
    Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.
    Eur Heart J. 2019 May 16. pii: 5490291. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  124. BONDE AN, Blanche P, Staerk L, Gerds TA, et al
    Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study.
    Eur Heart J. 2019 Apr 1. pii: 5424120. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  125. KHAN AA, Lip GYH
    Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
    Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: